_id
6919ef803c536f8df231854b
Ticker
TRX.LSE
Name
Tissue Regenix Group Plc
Exchange
LSE
Address
Phoenix Court, Garforth, United Kingdom, LS25 2GY
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://www.tissueregenix.com
Description
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies for bone graft substitutes, skin, and soft tissue biologics markets in the United States and internationally. The company operates in two segments, dCELL and BioRinse. It offers dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a technology that natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth. The company provides DermaPure, a decellularised dermal allograft that provides soft tissue with supplemental support, reinforcement, and/or protection from mechanical stress. In addition, it offers OrthoPure XT, provides biomechanically appropriate tissue scaffold for cellular repopulation and eventual regeneration; ConCelltrate 100, a verified osteoinductive bone matrix; MatrixCellect 100, a demineralised bone matrix (DBM) for orthopaedic; Matrix IQ Dermis, a human-derived dermal graft which is decellularised to remove cellular components and preserve the biological properties that promote revascularisation, repair, and augmentation of damaged tissue; and Matrix OI FlexIt, a thin pliable demineralised cortical allograft bone sheet. Further, it provides offers DentalFix, a mineralized particulate allograft that offer osteoconductive properties of natural bone; Matrix OI 100 DBM for non-structural bone-grafting; Matrix OI Strips and Blocks, a stem cell containment human scaffold; AmnioWorks to optimise membrane defects; and sports medicine products. Tissue Regenix Group plc was incorporated in 2006 and is based in Garforth, the United Kingdom.
Last Close
72500
Volume
-
Current Price
0.0725
Change
0
Last Updated
2025-12-30T11:40:24.821Z
Image
https://logo.clearbit.com/www.tissueregenix.com
Ipo Date
-
Market Cap
5164502
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
13796000
Cost Of Revenue
8026000
Gross Profit
5770000
Operating Expenses
6256000
Operating Income
-486000
Interest Expense
-
Pretax Income
-1016999
Net Income
-934000
Eps
-0.013082032255893515
Dividends Per Share
-
Shares Outstanding
71234507
Income Tax Expense
60000
EBITDA
5000
Operating Margin
-3.522760220353726
Total Other Income Expense Net
-530999
Cash
1075000
Short Term Investments
-
Receivables
4115000
Inventories
16696000
Total Current Assets
22791000
Property Plant Equipment
8087000
Total Assets
47188000
Payables
6845000
Short Term Debt
569000
Long Term Debt
10430000
Total Liabilities
18564000
Equity
29365000
Bs_currency_symbol
USD
Depreciation
527000
Change In Working Capital
-2346000
Cash From Operations
-202000
Capital Expenditures
50000
Cash From Investing
-592000
Cash From Financing
-2000
Net Change In Cash
1413000
Cf_currency_symbol
-
PE
-
PB
0.17627051038651453
ROE
-3.180657245019581
ROA
-1.9793167754513858
FCF
-252000
Fcf Percent
-0.018266164105537837
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2.5
Growth Investing Score
1.5
Momentum Investing Score
3.5
Net Net Investing Score
2
Quality Investing Score
2
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
13796000
Quarters > 0 > income Statement > cost Of Revenue
8026000
Quarters > 0 > income Statement > gross Profit
5770000
Quarters > 0 > income Statement > operating Expenses
6256000
Quarters > 0 > income Statement > operating Income
-486000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1016999
Quarters > 0 > income Statement > net Income
-934000
Quarters > 0 > income Statement > eps
-0.013082032255893515
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
71395635
Quarters > 0 > income Statement > income Tax Expense
60000
Quarters > 0 > income Statement > EBITDA
5000
Quarters > 0 > income Statement > operating Margin
-3.522760220353726
Quarters > 0 > income Statement > total Other Income Expense Net
-530999
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1075000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
4115000
Quarters > 0 > balance Sheet > inventories
16696000
Quarters > 0 > balance Sheet > total Current Assets
22791000
Quarters > 0 > balance Sheet > property Plant Equipment
8087000
Quarters > 0 > balance Sheet > total Assets
47188000
Quarters > 0 > balance Sheet > payables
6845000
Quarters > 0 > balance Sheet > short Term Debt
569000
Quarters > 0 > balance Sheet > long Term Debt
10430000
Quarters > 0 > balance Sheet > total Liabilities
18564000
Quarters > 0 > balance Sheet > equity
29365000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-934000
Quarters > 0 > cash Flow > depreciation
527000
Quarters > 0 > cash Flow > change In Working Capital
-2346000
Quarters > 0 > cash Flow > cash From Operations
-202000
Quarters > 0 > cash Flow > capital Expenditures
50000
Quarters > 0 > cash Flow > cash From Investing
-592000
Quarters > 0 > cash Flow > cash From Financing
-2000
Quarters > 0 > cash Flow > net Change In Cash
1413000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.013082032255893515
Quarters > 0 > ratios > PB
0.17627051038651453
Quarters > 0 > ratios > ROE
-3.180657245019581
Quarters > 0 > ratios > ROA
-1.9793167754513858
Quarters > 0 > ratios > FCF
-252000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.018266164105537837
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
12968225
Quarters > 1 > income Statement > cost Of Revenue
6154412
Quarters > 1 > income Statement > gross Profit
6813813
Quarters > 1 > income Statement > operating Expenses
6400304
Quarters > 1 > income Statement > operating Income
413509
Quarters > 1 > income Statement > interest Expense
312306
Quarters > 1 > income Statement > pretax Income
105156
Quarters > 1 > income Statement > net Income
-222172
Quarters > 1 > income Statement > eps
-0.003147241393451709
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
70592615
Quarters > 1 > income Statement > income Tax Expense
249845
Quarters > 1 > income Statement > EBITDA
828600
Quarters > 1 > income Statement > operating Margin
3.188632214508925
Quarters > 1 > income Statement > total Other Income Expense Net
-308353
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
3461000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
4582000
Quarters > 1 > balance Sheet > inventories
12712000
Quarters > 1 > balance Sheet > total Current Assets
20933000
Quarters > 1 > balance Sheet > property Plant Equipment
8983000
Quarters > 1 > balance Sheet > total Assets
45123000
Quarters > 1 > balance Sheet > payables
4569000
Quarters > 1 > balance Sheet > short Term Debt
626000
Quarters > 1 > balance Sheet > long Term Debt
9702000
Quarters > 1 > balance Sheet > total Liabilities
15781000
Quarters > 1 > balance Sheet > equity
30039000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-281000
Quarters > 1 > cash Flow > depreciation
520000
Quarters > 1 > cash Flow > change In Working Capital
-3206000
Quarters > 1 > cash Flow > cash From Operations
-1366241
Quarters > 1 > cash Flow > capital Expenditures
206358
Quarters > 1 > cash Flow > cash From Investing
-282500
Quarters > 1 > cash Flow > cash From Financing
870504
Quarters > 1 > cash Flow > net Change In Cash
3461000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.003147241393451709
Quarters > 1 > ratios > PB
0.1703773290555611
Quarters > 1 > ratios > ROE
-0.7396118379440061
Quarters > 1 > ratios > ROA
-0.4923697449194424
Quarters > 1 > ratios > FCF
-1572599
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.12126555484655764
Quarters > 1 > health Score
29
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
4520500
Quarters > 2 > income Statement > cost Of Revenue
6494295
Quarters > 2 > income Statement > gross Profit
2498000
Quarters > 2 > income Statement > operating Expenses
5902051
Quarters > 2 > income Statement > operating Income
-300000
Quarters > 2 > income Statement > interest Expense
476453
Quarters > 2 > income Statement > pretax Income
-593500
Quarters > 2 > income Statement > net Income
-643232
Quarters > 2 > income Statement > eps
-0.009124431377398164
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
70495571
Quarters > 2 > income Statement > income Tax Expense
38437
Quarters > 2 > income Statement > EBITDA
233541
Quarters > 2 > income Statement > operating Margin
-6.63643402278509
Quarters > 2 > income Statement > total Other Income Expense Net
-293500
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
4650000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
3028490
Quarters > 2 > balance Sheet > inventories
10358000
Quarters > 2 > balance Sheet > total Current Assets
19090000
Quarters > 2 > balance Sheet > property Plant Equipment
9018000
Quarters > 2 > balance Sheet > total Assets
43243000
Quarters > 2 > balance Sheet > payables
1207000
Quarters > 2 > balance Sheet > short Term Debt
642000
Quarters > 2 > balance Sheet > long Term Debt
5527000
Quarters > 2 > balance Sheet > total Liabilities
13888000
Quarters > 2 > balance Sheet > equity
30150000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-643232
Quarters > 2 > cash Flow > depreciation
389861
Quarters > 2 > cash Flow > change In Working Capital
500000
Quarters > 2 > cash Flow > cash From Operations
1364908
Quarters > 2 > cash Flow > capital Expenditures
153748
Quarters > 2 > cash Flow > cash From Investing
-323185
Quarters > 2 > cash Flow > cash From Financing
-564005
Quarters > 2 > cash Flow > net Change In Cash
447516
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.009124431377398164
Quarters > 2 > ratios > PB
0.16951671301824212
Quarters > 2 > ratios > ROE
-2.1334394693200665
Quarters > 2 > ratios > ROA
-1.4874823670883148
Quarters > 2 > ratios > FCF
1211160
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.26792611436787966
Quarters > 2 > health Score
53
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
11432271
Quarters > 3 > income Statement > cost Of Revenue
5817499
Quarters > 3 > income Statement > gross Profit
5614772
Quarters > 3 > income Statement > operating Expenses
5804525
Quarters > 3 > income Statement > operating Income
-189750
Quarters > 3 > income Statement > interest Expense
570883
Quarters > 3 > income Statement > pretax Income
-747663
Quarters > 3 > income Statement > net Income
-724146
Quarters > 3 > income Statement > eps
-0.010315937241659419
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
70196821
Quarters > 3 > income Statement > income Tax Expense
-49465
Quarters > 3 > income Statement > EBITDA
212459
Quarters > 3 > income Statement > operating Margin
-1.6597752100173273
Quarters > 3 > income Statement > total Other Income Expense Net
-563405
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3196602
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
4316671
Quarters > 3 > balance Sheet > inventories
8933810
Quarters > 3 > balance Sheet > total Current Assets
16447083
Quarters > 3 > balance Sheet > property Plant Equipment
6999646
Quarters > 3 > balance Sheet > total Assets
35346678
Quarters > 3 > balance Sheet > payables
4049238
Quarters > 3 > balance Sheet > short Term Debt
393000
Quarters > 3 > balance Sheet > long Term Debt
5958000
Quarters > 3 > balance Sheet > total Liabilities
11881857
Quarters > 3 > balance Sheet > equity
24109017
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-724146
Quarters > 3 > cash Flow > depreciation
389238
Quarters > 3 > cash Flow > change In Working Capital
-1124738
Quarters > 3 > cash Flow > cash From Operations
-977962
Quarters > 3 > cash Flow > capital Expenditures
357613
Quarters > 3 > cash Flow > cash From Investing
-357613
Quarters > 3 > cash Flow > cash From Financing
-219757
Quarters > 3 > cash Flow > net Change In Cash
-1748946
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.010315937241659419
Quarters > 3 > ratios > PB
0.21109402853297585
Quarters > 3 > ratios > ROE
-3.0036313799106784
Quarters > 3 > ratios > ROA
-2.0486960613384944
Quarters > 3 > ratios > FCF
-1335575
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-0.11682499478887441
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
28646000
Annuals > 0 > income Statement > cost Of Revenue
15025000
Annuals > 0 > income Statement > gross Profit
13621000
Annuals > 0 > income Statement > operating Expenses
13272000
Annuals > 0 > income Statement > operating Income
349000
Annuals > 0 > income Statement > interest Expense
882000
Annuals > 0 > income Statement > pretax Income
-564000
Annuals > 0 > income Statement > net Income
-713000
Annuals > 0 > income Statement > eps
-0.010100206657594424
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
70592615
Annuals > 0 > income Statement > income Tax Expense
289000
Annuals > 0 > income Statement > EBITDA
1364000
Annuals > 0 > income Statement > operating Margin
1.2183201843189277
Annuals > 0 > income Statement > total Other Income Expense Net
-913000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1870000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
4380000
Annuals > 0 > balance Sheet > inventories
14006000
Annuals > 0 > balance Sheet > total Current Assets
21270000
Annuals > 0 > balance Sheet > property Plant Equipment
8309000
Annuals > 0 > balance Sheet > total Assets
45346000
Annuals > 0 > balance Sheet > payables
2714000
Annuals > 0 > balance Sheet > short Term Debt
610000
Annuals > 0 > balance Sheet > long Term Debt
9734000
Annuals > 0 > balance Sheet > total Liabilities
16290000
Annuals > 0 > balance Sheet > equity
29819000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-392000
Annuals > 0 > cash Flow > depreciation
1046000
Annuals > 0 > cash Flow > change In Working Capital
-3588000
Annuals > 0 > cash Flow > cash From Operations
-1635000
Annuals > 0 > cash Flow > capital Expenditures
4069000
Annuals > 0 > cash Flow > cash From Investing
-4058000
Annuals > 0 > cash Flow > cash From Financing
3279000
Annuals > 0 > cash Flow > net Change In Cash
-2435000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.010100206657594424
Annuals > 0 > ratios > PB
0.17163434680908143
Annuals > 0 > ratios > ROE
-2.3910929273282133
Annuals > 0 > ratios > ROA
-1.572354783222335
Annuals > 0 > ratios > FCF
-5704000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.19912029602736858
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
29493000
Annuals > 1 > income Statement > cost Of Revenue
15453000
Annuals > 1 > income Statement > gross Profit
14040000
Annuals > 1 > income Statement > operating Expenses
14434000
Annuals > 1 > income Statement > operating Income
-394000
Annuals > 1 > income Statement > interest Expense
1138000
Annuals > 1 > income Statement > pretax Income
-1669000
Annuals > 1 > income Statement > net Income
-1713000
Annuals > 1 > income Statement > eps
-0.024323140806136758
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
70426760
Annuals > 1 > income Statement > income Tax Expense
-12000
Annuals > 1 > income Statement > EBITDA
446000
Annuals > 1 > income Statement > operating Margin
-1.3359102159834537
Annuals > 1 > income Statement > total Other Income Expense Net
-1275000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
4650000
Annuals > 1 > balance Sheet > short Term Investments
-1002401
Annuals > 1 > balance Sheet > receivables
3681000
Annuals > 1 > balance Sheet > inventories
10358000
Annuals > 1 > balance Sheet > total Current Assets
19090000
Annuals > 1 > balance Sheet > property Plant Equipment
9018000
Annuals > 1 > balance Sheet > total Assets
43243000
Annuals > 1 > balance Sheet > payables
1207000
Annuals > 1 > balance Sheet > short Term Debt
642000
Annuals > 1 > balance Sheet > long Term Debt
5527000
Annuals > 1 > balance Sheet > total Liabilities
13888000
Annuals > 1 > balance Sheet > equity
30150000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-1713000
Annuals > 1 > cash Flow > depreciation
977000
Annuals > 1 > cash Flow > change In Working Capital
-239000
Annuals > 1 > cash Flow > cash From Operations
1040000
Annuals > 1 > cash Flow > capital Expenditures
863000
Annuals > 1 > cash Flow > cash From Investing
-837000
Annuals > 1 > cash Flow > cash From Financing
-1512000
Annuals > 1 > cash Flow > net Change In Cash
-1299000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.024323140806136758
Annuals > 1 > ratios > PB
0.1693512470978441
Annuals > 1 > ratios > ROE
-5.681592039800995
Annuals > 1 > ratios > ROA
-3.9613347825081515
Annuals > 1 > ratios > FCF
177000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.006001424066727698
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
24476000
Annuals > 2 > income Statement > cost Of Revenue
10730810
Annuals > 2 > income Statement > gross Profit
9139618
Annuals > 2 > income Statement > operating Expenses
10751918
Annuals > 2 > income Statement > operating Income
-2009999
Annuals > 2 > income Statement > interest Expense
741000
Annuals > 2 > income Statement > pretax Income
-2828000
Annuals > 2 > income Statement > net Income
-2695000
Annuals > 2 > income Statement > eps
-0.03831106188341047
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
70345218
Annuals > 2 > income Statement > income Tax Expense
-232000
Annuals > 2 > income Statement > EBITDA
-1038999
Annuals > 2 > income Statement > operating Margin
-8.21212207877104
Annuals > 2 > income Statement > total Other Income Expense Net
-818000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
4945548
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
4326211
Annuals > 2 > balance Sheet > inventories
9046471
Annuals > 2 > balance Sheet > total Current Assets
18318230
Annuals > 2 > balance Sheet > property Plant Equipment
7434533
Annuals > 2 > balance Sheet > total Assets
38273339
Annuals > 2 > balance Sheet > payables
1075000
Annuals > 2 > balance Sheet > short Term Debt
1134000
Annuals > 2 > balance Sheet > long Term Debt
5258000
Annuals > 2 > balance Sheet > total Liabilities
13000249
Annuals > 2 > balance Sheet > equity
31252000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-2187890
Annuals > 2 > cash Flow > depreciation
921430
Annuals > 2 > cash Flow > change In Working Capital
-500089
Annuals > 2 > cash Flow > cash From Operations
-1294000
Annuals > 2 > cash Flow > capital Expenditures
884898
Annuals > 2 > cash Flow > cash From Investing
-1082000
Annuals > 2 > cash Flow > cash From Financing
910000
Annuals > 2 > cash Flow > net Change In Cash
-1760000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.03831106188341047
Annuals > 2 > ratios > PB
0.1631904615704595
Annuals > 2 > ratios > ROE
-8.623448099321642
Annuals > 2 > ratios > ROA
-7.041455149758426
Annuals > 2 > ratios > FCF
-2178898
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.08902181729040692
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
19746000
Annuals > 3 > income Statement > cost Of Revenue
8725344
Annuals > 3 > income Statement > gross Profit
5632210
Annuals > 3 > income Statement > operating Expenses
8614823
Annuals > 3 > income Statement > operating Income
-4378000
Annuals > 3 > income Statement > interest Expense
692000
Annuals > 3 > income Statement > pretax Income
-5142000
Annuals > 3 > income Statement > net Income
-4792000
Annuals > 3 > income Statement > eps
-0.06813518076738356
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
70330774
Annuals > 3 > income Statement > income Tax Expense
-157000
Annuals > 3 > income Statement > EBITDA
-3035000
Annuals > 3 > income Statement > operating Margin
-22.171579053985617
Annuals > 3 > income Statement > total Other Income Expense Net
-764000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
5691609
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
4021000
Annuals > 3 > balance Sheet > inventories
7175606
Annuals > 3 > balance Sheet > total Current Assets
16289268
Annuals > 3 > balance Sheet > property Plant Equipment
6715641
Annuals > 3 > balance Sheet > total Assets
34126767
Annuals > 3 > balance Sheet > payables
2574000
Annuals > 3 > balance Sheet > short Term Debt
118000
Annuals > 3 > balance Sheet > long Term Debt
4465000
Annuals > 3 > balance Sheet > total Liabilities
9473217
Annuals > 3 > balance Sheet > equity
25354941
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-3484320
Annuals > 3 > cash Flow > depreciation
793279
Annuals > 3 > cash Flow > change In Working Capital
-340288
Annuals > 3 > cash Flow > cash From Operations
-2975000
Annuals > 3 > cash Flow > capital Expenditures
1488398
Annuals > 3 > cash Flow > cash From Investing
-2044000
Annuals > 3 > cash Flow > cash From Financing
-192000
Annuals > 3 > cash Flow > net Change In Cash
-5259000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.06813518076738356
Annuals > 3 > ratios > PB
0.20110404181181096
Annuals > 3 > ratios > ROE
-18.89966929917131
Annuals > 3 > ratios > ROA
-14.04176375687741
Annuals > 3 > ratios > FCF
-4463398
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.22604061582092574
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.013082032255893515
Valuation > metrics > PB
0.17627051038651453
Valuation > final Score
70
Valuation > verdict
82.4% Undervalued
Profitability > metrics > ROE
-3.180657245019581
Profitability > metrics > ROA
-4.098108902637006
Profitability > metrics > Net Margin
-0.06770078283560452
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6321811680572109
Risk > metrics > Interest Coverage
-0.47553862577164946
Risk > final Score
46
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.074049096304289
Liquidity > metrics > Quick Ratio
0.8220933369301322
Liquidity > final Score
91
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
53
Prev Risks > 1
57
Prev Risks > 2
59
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:04:31.635Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.01
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.01
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-06-30
Earnings History > 1 > report Date
2024-09-10
Earnings History > 1 > date
2024-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-12-31
Earnings History > 2 > report Date
2023-03-23
Earnings History > 2 > date
2022-12-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-06-30
Earnings History > 3 > report Date
2022-09-07
Earnings History > 3 > date
2022-06-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-03-31
Earnings History > 4 > report Date
2022-04-26
Earnings History > 4 > date
2022-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-06-30
Earnings History > 5 > report Date
2021-09-08
Earnings History > 5 > date
2021-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-03-31
Earnings History > 6 > report Date
2021-04-28
Earnings History > 6 > date
2021-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-06-30
Earnings History > 7 > report Date
2020-09-02
Earnings History > 7 > date
2020-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-03-31
Earnings History > 8 > report Date
2020-06-05
Earnings History > 8 > date
2020-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-06-30
Earnings History > 9 > report Date
2019-09-10
Earnings History > 9 > date
2019-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-25
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
-36
Earnings History > 10 > eps Difference
36
Earnings History > 10 > surprise Percent
100
Earnings History > 11 > period
2018-06-30
Earnings History > 11 > report Date
2018-09-03
Earnings History > 11 > date
2018-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
-44
Earnings History > 11 > eps Difference
44
Earnings History > 11 > surprise Percent
100
Earnings History > 12 > period
2017-12-31
Earnings History > 12 > report Date
2018-03-26
Earnings History > 12 > date
2017-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-06-30
Earnings History > 13 > report Date
2017-09-28
Earnings History > 13 > date
2017-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.01
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.01
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-03-31
Earnings History > 14 > report Date
2017-06-02
Earnings History > 14 > date
2017-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.01
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.01
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-09-30
Earnings History > 15 > report Date
2016-10-12
Earnings History > 15 > date
2016-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.01
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.01
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-03-31
Earnings History > 16 > report Date
2016-05-23
Earnings History > 16 > date
2016-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.01
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.01
Earnings History > 16 > surprise Percent
-
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies for bone graft substitutes, skin, and soft tissue biologics markets in the United States and internationally. The company operates in two segments, dCELL and BioRinse. It offers dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a technology that natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth. The company provides DermaPure, a decellularised dermal allograft that provides soft tissue with supplemental support, reinforcement, and/or protection from mechanical stress. In addition, it offers OrthoPure XT, provides biomechanically appropriate tissue scaffold for cellular repopulation and eventual regeneration; ConCelltrate 100, a verified osteoinductive bone matrix; MatrixCellect 100, a demineralised bone matrix (DBM) for orthopaedic; Matrix IQ Dermis, a human-derived dermal graft which is decellularised to remove cellular components and preserve the biological properties that promote revascularisation, repair, and augmentation of damaged tissue; and Matrix OI FlexIt, a thin pliable demineralised cortical allograft bone sheet. Further, it provides offers DentalFix, a mineralized particulate allograft that offer osteoconductive properties of natural bone; Matrix OI 100 DBM for non-structural bone-grafting; Matrix OI Strips and Blocks, a stem cell containment human scaffold; AmnioWorks to optimise membrane defects; and sports medicine products. Tissue Regenix Group plc was incorporated in 2006 and is based in Garforth, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATissue Regenix Group Performance Insights Amid FTSE All-Share Activity Kalkine Media
Read more →(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Tissue Regenix Group Plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.01
EPS Estimate
0
EPS Difference
-0.01
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.